Login / Signup

Erythropoietin prevents necrotizing enterocolitis in very preterm infants: a randomized controlled trial.

Yong WangJuan SongHuiqing SunFalin XuKenan LiChunxia NieXiaoli ZhangXirui PengLei XiaZiyun ShenXiao YuanShan ZhangXue DingYaodong ZhangWenqing KangLiling QianWenhao ZhouXiaoyang WangXiuyong ChengChanglian Zhu
Published in: Journal of translational medicine (2020)
Repeated low-dose rhEPO treatment is beneficial against NEC in very preterm infants. Trial registration The protocol was registered retrospectively at ClinicalTrials.gov (NCT03919500) on April 18, 2019. https://clinicaltrials.gov/ct2/show/NCT03919500.
Keyphrases